Newsroom

SEATTLE--(BUSINESS WIRE)--Amazon Pharmacy today announced it will expand its Same-Day prescription delivery service to nearly 4,500 U.S. cities and towns by the end of 2026—adding nearly 2,000 new communities over the course of the year. The expansion will bring fast, reliable medication delivery to millions of customers nationwide, including new states such as Idaho and Massachusetts, where pharmacy closures, staffing shortages, and transportation barriers have historically limited access to c...

MILWAUKEE--(BUSINESS WIRE)--Directors of The Marcus Corporation (NYSE: MCS) today declared a regular quarterly cash dividend of $0.08 per share of common stock. The dividend will be paid March 16, 2026, to shareholders of record on February 25, 2026. The Board of Directors also declared a dividend of $0.073 per share on the Class B common stock. The dividend on the Class B common stock, which is not publicly traded, will also be paid March 16, 2026, to shareholders of record on February 25, 202...

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--In recognition of Kevin J. Tracey, MD’s decades-long pursuit into unraveling the mysteries of the brain’s connection to the body and control of inflammation through technology, TIME has named the president and CEO of the Feinstein Institutes for Medical Research at Northwell Health an “Innovator” on its 2026 TIME100 Health list. The recognition spotlights 100 of the world’s most influential leaders transforming global health. Read Dr. Tracey’s profile here...

LONDON--(BUSINESS WIRE)--  Re: WILMINGTON CARDS 2021-1 PLC GBP 3,350,000,000.00 MATURING: 18-Mar-2037 ISIN: XS2293684192 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 19-Jan-2026 TO 18-Feb-2026 HAS BEEN FIXED AT 4.63 PCT DAY BASIS: ACTUAL/365(GBP) INTEREST PAYABLE VALUE 18-Feb-2026 WILL AMOUNT TO: GBP 12,751,302.33 PER GBP 3,350,000,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: LACE FUNDING 2025-1 PLC GBP 350,000,000.00 MATURING: 21-Nov-2074 ISIN: XS2982091360 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Aug-2025 TO 21-Nov-2025 HAS BEEN FIXED AT 4.54 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 21-Nov-2025 WILL AMOUNT TO: GBP 3,530,303.94 PER GBP 308,688,603.59 DENOMINATION  ...

DALLAS--(BUSINESS WIRE)--PrimeLending®, a PlainsCapital Company, has been named the 2025 Best-in-Class Lender for Overall Satisfaction in the large independent lender segment by MortgageCX, earning the program’s top honor based on verified borrower feedback. In addition to the No. 1 overall ranking, PrimeLending placed first in six of 10 customer experience categories evaluated by MortgageCX: Overall Borrower Satisfaction Loan Originators Processors Net Promoter Score (NPS) Online Tools Applica...

SAN FRANCISCO--(BUSINESS WIRE)--15Five, the AI-powered performance management platform used by over 3,000 companies, today debuted Amaya, a powerful new Ask-Me-Anything (AMA) AI agent built directly into the 15Five platform. Amaya delivers a ChatGPT-like conversational experience and utilizes data from across all 15Five features to answer questions like: What are employees saying about their managers in recent reviews? Which factors are most strongly influencing engagement? How do engagement or...

SAN CARLOS, California--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), una empresa global especializada en oncología, publicará sus resultados financieros del cuarto trimestre y del año completo 2025 el jueves 26 de febrero de 2026, antes de la apertura de los mercados financieros. Tras la publicación de los resultados financieros, la empresa ofrecerá una transmisión en vivo con la gerencia a las 8:00 a. m. hora del Este. Se puede acceder a la transmisión en vivo...

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), een internationaal oncologiebedrijf, zal de financiële resultaten van het vierde kwartaal en het volledige boekjaar 2025 op donderdag 26 februari 2026 bekendmaken voordat de financiële markten worden geopend. Na de release van de financiële cijfers zal het bedrijf een live webcast met het bestuur hosten om 8.00 uur a.m. ET. De live webcast van dit evenement is toegankelijk via de investeerdersrubr...

SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (NASDAQ : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale d'oncologie, présentera ses résultats financiers du quatrième trimestre et de l'exercice 2025 le jeudi 26 février 2026 avant l'ouverture des marchés financiers. À la suite de la publication des états financiers, la société organisera une webdiffusion en direct avec son équipe de direction à 8h00, heure de l'Est. La webdiffusion en direct de cet événement pourra être s...